Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines

2013 ◽  
Vol 29 (4) ◽  
pp. 365-369 ◽  
Author(s):  
Steven T. Bird ◽  
Abraham G. Hartzema ◽  
Mahyar Etminan ◽  
James M. Brophy ◽  
Joseph A. C. Delaney
2019 ◽  
Vol 91 (6) ◽  
pp. 810-815 ◽  
Author(s):  
Nesrin Damla Eyupoglu ◽  
Ezgi Caliskan Guzelce ◽  
Aylin Acikgoz ◽  
Esra Uyanik ◽  
Bodil Bjørndal ◽  
...  

2017 ◽  
Vol 28 (5) ◽  
pp. 371-383 ◽  
Author(s):  
Amy L. Shafrir ◽  
Helena Schock ◽  
Elizabeth M. Poole ◽  
Kathryn L. Terry ◽  
Rulla M. Tamimi ◽  
...  

1979 ◽  
Vol 11 (S6) ◽  
pp. 119-141 ◽  
Author(s):  
Robert B. Greenblatt ◽  
Camran Nezhat ◽  
Virginia P. McNamara

The United States Food and Drug Administration and the International Planned Parenthood Federation recommend that women over the age of 40 should utilize forms of contraception other than the pill. This decision was reached as a result of the 1975 clinical papers by Mann and his associates (Mann et al., 1975; Mann & Inman, 1975) and the epidemiological reports of the Royal College of General Practitioners (1977), Mann, Inman & Thorogood (1976) and Vessey, McPherson & Johnson (1977). Several authoritative bodies believed it prudent to suggest that the age limit for oral contraceptive use be lowered to 35, and even to 30 years (Anon, 1977; Planned Parenthood memorandum, 1977). The investigations of Inman & Vessey (1968) point to a precarious rise in mortality figures for women over age 35 on oral contraceptives.


Ophthalmology ◽  
2016 ◽  
Vol 123 (4) ◽  
pp. 729-736 ◽  
Author(s):  
Ye Elaine Wang ◽  
Caitlin Kakigi ◽  
Diego Barbosa ◽  
Travis Porco ◽  
Rebecca Chen ◽  
...  

Author(s):  
Damla Eyupoglu ◽  
Koray Ergunay ◽  
Aylin Acikgoz ◽  
Yakut Akyon ◽  
Engin Yilmaz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document